OPKO Health, Inc. (OPK) Stock Score, Valuation & Financial Research
OPKO Health, Inc. is in the Healthcare sector and Medical - Diagnostics & Research industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 15/100.
Quick answer for OPK
OPKO Health, Inc. currently has a Wall Street Score of 15/100. The stored market price is $1.61. Its financial score is 18/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What OPKO Health, Inc. does
OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease detection, diagnosis, evaluation, monitoring, and treatment, covering areas such as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare. BioReference serves a diverse client base, including medical practices, clinics, hospitals, employers, and government entities. Additionally, this segment provides a cutting-edge diagnostic instrument system designed for immediate, point-of-care blood test results, alongside its specialized 4Ksco
OPK financial snapshot
- Wall Street Score:
- 15/100
- Current price:
- $1.61
- Market capitalization:
- $1.20B
- Revenue:
- $581.1M
- Net income:
- $-212.9M
- Free cash flow:
- $-190.8M
- Cash:
- $341.9M
- Total debt:
- $396.9M
- EPS:
- -0.30
- Financial score:
- 18/100
- Valuation score:
- 0/100
- Revenue score:
- 7/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $-190.8M, showing cash burn in the current stored period.
- The balance sheet shows $341.9M of cash versus $396.9M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 18/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research OPK
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.